Patient Guide: Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT02286089
Status: ACTIVE_NOT_RECRUITING
Condition: Age-Related Macular Degeneration
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • San Francisco, California
  • • Cincinnati, Ohio
  • • Philadelphia, Pennsylvania
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration - Join Clinical Trial NCTNCT02286089

How to Join This Clinical Trial - NCTNCT02286089

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Age-Related Macular Degeneration. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Age-Related Macular Degeneration. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Age-Related Macular Degeneration
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT02286089 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

San Francisco, California 94109 - United States

Status: Contact for availability

Clinical Research Site

Cincinnati, Ohio 45242 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19107 - United States

Status: Contact for availability

Clinical Research Site

Jerusalem, 9112001 - Israel

Status: Contact for availability

Clinical Research Site

Petah Tikva, 4941492 - Israel

Status: Contact for availability

Clinical Research Site

Rehovot, 76100 - Israel

Status: Contact for availability

Clinical Research Site

Tel Aviv, 6423906 - Israel

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Age-Related Macular Degeneration:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships